DeTIL-0255

· Nurix Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DeTIL-0255, covering 2024-05-03 to 2024-05-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DeTIL-0255 in Adults With Advanced Malignancies [Phase 1]